Early SGLT2i therapy in patients with T2DM and ACS results in reduction in cardiovascular and renal outcomes- a propensity score matched multi-model retrospective registry analysis

Back

ESC2025 Premium Access

Early SGLT2i therapy in patients with T2DM and ACS results in reduction in cardiovascular and renal outcomes- a propensity score matched multi-model retrospective registry analysis

Session: Diabetes and the heart (1)

Topic: Pharmacotherapy

Speaker: Doctor M. Shah (Lincoln, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Muhammad Usman Shah

United Lincolnshire NHS Trust, Lincoln (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Association between the oxidative balance score and mortality in patients with metabolic syndrome

Speaker: Professor J. Gao (Tianjin, CN)

Dietary inflammatory index in progression and mortality risk of cardiovascular-kidney-metabolic syndrome: NHANES 1999-2018

Speaker: Doctor Y. Wang (Beijing, CN)

The impact of microalbuminuria and proteinuria on cardiovascular outcomes in individuals with type 2 diabetes mellitus: a population-based, electronic health records study

Speaker: Doctor M. Mohamed (London, GB)

Lower glomerular filtration rate is correlated with higher left heart remodeling in individuals with type 2 diabetes

Speaker: Doctor N. Espinola-Zavaleta (Mexico City, MX)

Associations of epicardial fat and markers of subclinical diastolic dysfunction in metabolic syndrome

Speaker: Mrs B. Gustafsson (Turku, FI)

Access the full session

Diabetes and the heart (1)

Speakers: Doctor M. Shah, Professor J. Gao, Doctor Y. Wang, Doctor M. Mohamed, Doctor N. Espinola-Zavaleta...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources